HOUSTON--(BUSINESS WIRE)--CytoGenix, Inc. (CYGX:OB) has received notices of allowances for grant of patent applications covering the technology for expressing ssDNA In Vivo, from the Indian and European Community Patent Offices. These notices follow the previous notice of allowance for these applications from the Peoples Republic of China.
